An Open Label Trial of Duloxetine in the Treatment of Irritable Bowel Syndrome and Comorbid Generalized Anxiety Disorder.
Phase of Trial: Phase IV
Latest Information Update: 01 Jan 2014
At a glance
- Drugs Duloxetine (Primary)
- Indications Generalised anxiety disorder; Irritable bowel syndrome
- Focus Therapeutic Use
- 01 Sep 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 17 Jan 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 22 Jun 2011 Planned end date changed from 1 Mar 2011 to 1 Jan 2012 as reported by ClinicalTrials.gov.